Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
How do intellectual property rights and licensing structures influence access to CRISPR technologies? Could the right to science act as a complementary legal instrument to promote socially beneficial innovation?
The prospect of reduced funding, more stringent conflict-of-interest policies and research reproducibility are among the growing challenges to sustained US leadership in biomedical translation.
A systematic, prospective analysis of the interplay between science and technology in biomedicine can illuminate the pathway for translating scientific insights into tangible innovations for societal benefit.
